Riskpilot← Back to searchSign inGet full accessInfomed Sverige AB
ABActiveOrg 5592978430Åbovägen 38Literary creation and musical composition activities · NACE 9011Est. 20211 employees
Revenue 2025
SEK 6
-100% vs 2024
EBITDA margin
-4425716.7%
+62% vs 2024
Equity ratio
90.9%
Financial strength
Net profit 2025
SEK -274K
+62% vs 2024
| Revenue | SEK 6 | -100% |
| EBITDA | SEK -266K | +62% |
| Net profit | SEK -274K | +62% |
| Total assets | SEK 151K | -65% |
| Equity | SEK 137K | -67% |
| Employees | 1 | — |
Legal name
Infomed Sverige AB
Org number
5592978430
Legal form
Aktiebolag
NACE code
9011 · Literary creation and musical composition activities
Founded
21 januari 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget tar fram kurslitteratur till utbildningar inom vård och omsorgsområdet. Även föreläsningar inom vård och omsorgsområdet erbjuds samt att filmer finns på internet.
Address
Åbovägen 38
Email
gustav@infomed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 757 | 3 757 | 4 | 50 | 0 |
| Staff expenses | −589 | — | −527 | −559 | −76 |
| EBITDA | 2 737 | 2 738 | −744 | −698 | −266 |
| Depreciation & amort. | −1 | −1 | −9 | −9 | −8 |
| EBIT | 2 737 | 2 737 | −753 | −707 | −274 |
| Net financials | −1 | −1 | 4 | −12 | −1 |
| Profit before tax | 2 056 | 2 056 | −69 | −719 | −274 |
| Tax | −0 | −424 | — | — | — |
| Net profit | 1 632 | 1 632 | −69 | −719 | −274 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 986 | 2 986 | 1 754 | 431 | 151 |
| Equity | 1 662 | 1 662 | 1 131 | 412 | 137 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 644 | 644 | 623 | 20 | 14 |
| Total debt | 644 | 644 | 623 | 20 | 14 |
EBITDA margin
-4425716.7%
This company
15.8%
Market median
-28010965% vs market
20222025
Equity ratio
90.9%
This company
38.2%
Market median
+138% vs market
20222025
Return on equity
-199.9%
This company
18.4%
Market median
-1186% vs market
20222025
Net profit margin
-4574266.7%
This company
8.1%
Market median
-56472528% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Infomed Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Oscar Henning Sebastian Hållén | Deputy Board Member | 0 companies |
| Carl Gustav Alexander Hållén | Board of Directors | 0 companies |